In our 30-Week Tirzepatide Reset protocol at CFP Weight Loss, we find most patients do best injecting retatrutide in the morning. This aligns with natural circadian rhythms and minimizes nighttime hunger or disrupted sleep that some experience with evening doses. Clinical observations from hundreds of patients show morning administration supports steadier energy, better appetite control during daylight hours, and improved alignment with our Japanese-style walking intervals. However, a small subset with strong insulin resistance or shift-work schedules may tolerate night dosing better. The key is consistency and individual response rather than rigid rules.
Success in the 30-Week Tirzepatide Reset depends on tracking far more than the scale. We require patients to log four core metrics daily: (1) fasting glucose and morning ketones using a simple meter (target 70-90 mg/dL glucose and 0.5-2.0 mmol/L ketones after week 6), (2) waist circumference at the navel (aim for 0.5-1 inch loss per 10 days), (3) energy and hunger scores on a 1-10 scale, and (4) daily steps with heart-rate variability via wearable. These numbers reveal metabolic freedom long before visible changes appear. We also track inflammatory markers every 70 days—CRP, fasting insulin, and A1C—because lectin-driven inflammation often blocks progress even when calories are controlled.
Obsessing over daily weight is the fastest way to quit. Instead, focus on non-scale victories that prove your metabolism is healing. In the book The 30-Week Tirzepatide Reset, I outline 69 specific steps that include weekly body-composition scans, clothing fit measurements, sleep quality (target 7-9 hours with morning HRV above 60), and lab trends. Patients following our lectin-free low-carb meal plans with 221 tested recipes typically see 1.5-3 pounds of fat loss weekly during active low-dose cycling phases while preserving muscle. Use weekly progress photos in consistent lighting and the CFP app’s trend graphs. True success appears when your body no longer fights to regain weight after the 30 weeks end.
Our protocol cycles one 10-15 mg box of retatrutide across three 70-day phases: weeks 1-4 at 2-4 mg, weeks 5-8 at 6-8 mg, then strategic micro-dosing or pause. Pair this with Detox Drops to clear toxins that impair hypothalamic signaling, red light therapy three times weekly for mitochondrial support, and chaotic intermittent fasting in maintenance. John, a 58-year-old CFP patient with joint pain and A1C of 8.1, injected mornings, followed the exact plan, lost 38 pounds, dropped his A1C to 5.7, and now maintains effortlessly. Morning dosing worked best for him because it curbed daytime cravings that once led to evening bingeing. This integrated system—real food, targeted drops, movement, and intelligent cycling—delivers the metabolic freedom most patients have never experienced before.